These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 22683888)

  • 1. TNF-α inhibits PPARβ/δ activity and SIRT1 expression through NF-κB in human adipocytes.
    Serrano-Marco L; Chacón MR; Maymó-Masip E; Barroso E; Salvadó L; Wabitsch M; Garrido-Sánchez L; Tinahones FJ; Palomer X; Vendrell J; Vázquez-Carrera M
    Biochim Biophys Acta; 2012 Sep; 1821(9):1177-85. PubMed ID: 22683888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1.
    Barroso E; Eyre E; Palomer X; Vázquez-Carrera M
    Biochem Pharmacol; 2011 Feb; 81(4):534-43. PubMed ID: 21146504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells.
    Alvarez-Guardia D; Palomer X; Coll T; Serrano L; Rodríguez-Calvo R; Davidson MM; Merlos M; El Kochairi I; Michalik L; Wahli W; Vázquez-Carrera M
    Biochim Biophys Acta; 2011 Feb; 1811(2):59-67. PubMed ID: 21070867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2.
    Rodríguez-Calvo R; Serrano L; Coll T; Moullan N; Sánchez RM; Merlos M; Palomer X; Laguna JC; Michalik L; Wahli W; Vázquez-Carrera M
    Diabetes; 2008 Aug; 57(8):2149-57. PubMed ID: 18443198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARβ/δ ameliorates fructose-induced insulin resistance in adipocytes by preventing Nrf2 activation.
    Barroso E; Rodríguez-Rodríguez R; Chacón MR; Maymó-Masip E; Ferrer L; Salvadó L; Salmerón E; Wabistch M; Palomer X; Vendrell J; Wahli W; Vázquez-Carrera M
    Biochim Biophys Acta; 2015 May; 1852(5):1049-58. PubMed ID: 25728706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the p65/RelA subunit of NF-kappaB in TNF-alpha-induced SIRT1 expression in vascular smooth muscle cells.
    Zhang HN; Li L; Gao P; Chen HZ; Zhang R; Wei YS; Liu DP; Liang CC
    Biochem Biophys Res Commun; 2010 Jul; 397(3):569-75. PubMed ID: 20617556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARβ/δ agonist GW501516 inhibits TNFα-induced repression of adiponectin and insulin receptor in 3T3-L1 adipocytes.
    Kim WJ; Lee W; Jung Y; Jang HJ; Kim YK; Kim SN
    Biochem Biophys Res Commun; 2019 Mar; 510(4):621-628. PubMed ID: 30739791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIRT1 regulates TNF-α-induced expression of CD40 in 3T3-L1 adipocytes via NF-κB pathway.
    Lin QQ; Yan CF; Lin R; Zhang JY; Wang WR; Yang LN; Zhang KF
    Cytokine; 2012 Nov; 60(2):447-55. PubMed ID: 22717288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of peroxisome proliferator-activated receptor-β/δ on sepsis induced acute lung injury.
    Wang C; Zhou G; Zeng Z
    Chin Med J (Engl); 2014; 127(11):2129-37. PubMed ID: 24890166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARα agonist fenofibrate attenuates TNF-α-induced CD40 expression in 3T3-L1 adipocytes via the SIRT1-dependent signaling pathway.
    Wang W; Lin Q; Lin R; Zhang J; Ren F; Zhang J; Ji M; Li Y
    Exp Cell Res; 2013 Jun; 319(10):1523-33. PubMed ID: 23603572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARbeta/delta agonist stimulates human lung carcinoma cell growth through inhibition of PTEN expression: the involvement of PI3K and NF-kappaB signals.
    Han S; Ritzenthaler JD; Zheng Y; Roman J
    Am J Physiol Lung Cell Mol Physiol; 2008 Jun; 294(6):L1238-49. PubMed ID: 18390835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human adipocytes are highly sensitive to intermittent hypoxia induced NF-kappaB activity and subsequent inflammatory gene expression.
    Taylor CT; Kent BD; Crinion SJ; McNicholas WT; Ryan S
    Biochem Biophys Res Commun; 2014 May; 447(4):660-5. PubMed ID: 24755071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of peroxisome proliferator-activated receptor-β/-δ (PPAR-β/-δ) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6-stimulated adipocytes.
    Serrano-Marco L; Rodríguez-Calvo R; El Kochairi I; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
    Diabetes; 2011 Jul; 60(7):1990-9. PubMed ID: 21617181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin prevents peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) downregulation in lipopolysaccharide-stimulated H9c2 cells.
    Planavila A; Sánchez RM; Merlos M; Laguna JC; Vázquez-Carrera M
    Biochim Biophys Acta; 2005 Sep; 1736(2):120-7. PubMed ID: 16139565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension-Causing Mutation in Peroxisome Proliferator-Activated Receptor γ Impairs Nuclear Export of Nuclear Factor-κB p65 in Vascular Smooth Muscle.
    Mukohda M; Lu KT; Guo DF; Wu J; Keen HL; Liu X; Ketsawatsomkron P; Stump M; Rahmouni K; Quelle FW; Sigmund CD
    Hypertension; 2017 Jul; 70(1):174-182. PubMed ID: 28507170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells.
    Serrano-Marco L; Barroso E; El Kochairi I; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
    Diabetologia; 2012 Mar; 55(3):743-51. PubMed ID: 22179221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aucubin, a naturally occurring iridoid glycoside inhibits TNF-α-induced inflammatory responses through suppression of NF-κB activation in 3T3-L1 adipocytes.
    Park KS
    Cytokine; 2013 Jun; 62(3):407-12. PubMed ID: 23612013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear factor-kappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy.
    Planavila A; Laguna JC; Vázquez-Carrera M
    J Biol Chem; 2005 Apr; 280(17):17464-71. PubMed ID: 15728586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histidine supplementation alleviates inflammation in the adipose tissue of high-fat diet-induced obese rats via the NF-κB- and PPARγ-involved pathways.
    Sun X; Feng R; Li Y; Lin S; Zhang W; Li Y; Sun C; Li S
    Br J Nutr; 2014 Aug; 112(4):477-85. PubMed ID: 24833547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All-trans-retinoic acid represses obesity and insulin resistance by activating both peroxisome proliferation-activated receptor beta/delta and retinoic acid receptor.
    Berry DC; Noy N
    Mol Cell Biol; 2009 Jun; 29(12):3286-96. PubMed ID: 19364826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.